PEBBLE LABS
Dead / Cancelled — Cancelled — Section 8 (as of 13 Feb 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88225549
- Registration number
- 5819332
- Mark type
- Stylized text
- Filed
- 11 Dec 2018
- Published for opposition
- 14 May 2019
- Registered
- 30 Jul 2019
- Attorney of record
- David S. Kerr
Goods and services
- Class 042 — Scientific and technological services: Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Design and development of biological RNA-based therapeutic agents for the prevention and treatment of infectious diseases in plants and animals for use in pharmaceuticals, biotechnology, and medical and diagnostic applications; Research and development of biopharmaceutical compounds; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target pathogen genes in plants and animals; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit aquaculture-related diseases; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit mosquito populations; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of genetically engineered organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target pathogen genes in plants and animals; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit aquaculture-related diseases; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit mosquito populations; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce that produce eukaryotic-like mRNA; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce that produce commercial compounds; Research and development of genetically engineered organisms, namely, genetically engineered algae that produce that produce waxes; Research and development of pharmaceuticals, therapeutics, and biologics; Research and development of new biological products for therapeutic use
Owner
- PEBBLE LABS, INC., LOS ALAMOS, NM, US
- PEBBLE LABS INC., SANTA FE, NM, US
- Pebble Labs Inc., Los Alamos, NM, CA
- Pebble Labs Inc., Los Alamos, NM, CA
- Pebble Labs Inc., Los Alamos, NM, CA
Prosecution history
- 13 Feb 2026 — CANCELLED SEC. 8 (6-YR)
- 30 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Jan 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 14 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2019 — PUBLISHED FOR OPPOSITION
- 24 Apr 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Apr 2019 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 05 Apr 2019 — ASSIGNED TO LIE
- 14 Mar 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Mar 2019 — EXAMINER'S AMENDMENT ENTERED
- 14 Mar 2019 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Mar 2019 — EXAMINERS AMENDMENT E-MAILED
- 14 Mar 2019 — EXAMINERS AMENDMENT -WRITTEN